(MedPage Today) — The FDA approved mepolizumab (Nucala) for adults with inadequately controlled chronic obstructive pulmonary disease (COPD), drugmaker GSK announced on Thursday.
Labeling for the interleukin-5 (IL-5) antagonist stipulates use…
Source link : https://www.medpagetoday.com/pulmonology/smokingcopd/115751
Author :
Publish date : 2025-05-23 17:32:00
Copyright for syndicated content belongs to the linked Source.
